溶瘤单纯疱疹病毒 G47∆ 通过协同激活固有免疫和适应性免疫应答增强诱导 ADCC 的分子靶向治疗
Oncolytic Herpes Virus G47∆ Potentiates ADCC-Inducing Molecular Targeted Therapy via Coordinated Activation of Innate and Adaptive Immune Responses.
68.2分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Oncolytic Herpes Virus G47∆ Potentiates ADCC-Inducing Molecular Targeted Therapy via Coordinated Activation of Innate and Adaptive Immune Responses.
Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。